Pig-to-Human Xenotransplantation Status
Pig-to-human organ xenotransplantation remains investigational. The US Food and Drug Administration (FDA) regulates xenotransplantation and provides guidance on preclinical and clinical requirements through its xenotransplantation materials. [1]
Current Clinical Milestones in Pig Organ Transplantation
A first pig heart transplant into an adult human used a genetically engineered pig heart and occurred on January 7, 2022, at the University of Maryland. [2], [3]
Pig kidneys have also been transplanted into human recipients under research conditions, including neurologically deceased subjects, to evaluate early graft function and immunologic compatibility. [4], NYU Langone News
Key Biological Barriers
Hyperacute and acute rejection are driven by pre-existing human antibodies to pig carbohydrate antigens, with downstream complement activation. [2], [3]
Genetic engineering of donor pigs targets these antigenic pathways to reduce antibody-mediated injury. [2], [3]
Major Safety and Regulatory Focus Areas
FDA oversight centers on source animal and product controls, pathogen safety, and clinical follow-up planning for xenotransplantation products. [5]
Investigational use in humans requires approvals consistent with xenotransplantation regulatory expectations rather than routine clinical deployment. [1]
Ethical and Public-Health Considerations
Informed consent and long-term monitoring planning are central ethical elements because xenotransplantation differs from standard allotransplantation in pathogen and immune compatibility considerations. [1]
Program-level governance of xenotransplantation includes assessment of stakeholder perspectives and coordination of research activities through organizations involved in transplant policy and research support. UNOS
Practical Clinical Position
Pig organ transplantation is not a standard-of-care option for end-stage organ failure. [1]
Progress is occurring through carefully controlled studies that build immunologic tolerance strategies, graft conditioning approaches, and safety monitoring frameworks required for broader clinical testing. [3]